FISHER ANDREW (General Counsel) sold 18.2% of their position (80K shares) of VERONA PHARMA PLC on the open market
Open‑market sale worth $685.6K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/16/2025ACC: 0001104659-25-050047
Officer· General Counsel
Since Mar 2024
-80K
Net shares
Net seller
$685.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
80K acquired · 160K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+80K
Price / share
$2.11
Trade value
$169.04K
% of position
22.2%
5/15/2025
360K→440K
Ordinary Shares
Direct
Shares
−80K
Price / share
$8.57
Trade value
$685.60K
% of position
18.2%
5/15/2025
440K→360K
Total
Net shares
+0.00
Net value
-$516.56K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 5/15/2025 | M · Option Exercise | +80K | $2.11 | $169.04K | 22.2% | 360K | 440K |
| Ordinary Shares Direct | 5/15/2025 | S · Sale | −80K | $8.57 | $685.60K | 18.2% | 440K | 360K |
| Total | +0.00 | -$516.56K | ||||||
Derivative Transactions1
Share Options (Right to Buy)
Direct
Converts to
Ordinary Shares
80K shares
Shares
−80K
Strike price
2.113
Held after
2.32M
Exercisable
—
5/15/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Share Options (Right to Buy) Direct | Ordinary Shares80K shares | 5/15/2025 | M · Option Exercise | −80K | 2.113 | — | 2.32M |